What to expect when you take Diflucan and Topamax?

Do you take Diflucan and Topamax? Find out below what new side effects and undetected conditions people may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here




Female

Females aged 50 to 59 :

10,629 related reports were analyzed:

Most common symptoms:

Anaemia (lack of blood)
  • 6.27% for females aged 50 (±5) who take Diflucan
Diarrhea
  • 8.13% for females aged 50 (±5) who take Diflucan
Dizziness
  • 5.95% for females aged 50 (±5) who take Topamax
  • 5.09% for females aged 50 (±5) who take Diflucan
Drug ineffective
  • 6.71% for females aged 50 (±5) who take Topamax
Dyspnea (difficult or laboured breathing)
  • 6.08% for females aged 50 (±5) who take Diflucan
Fatigue (feeling of tiredness)
  • 7.6% for females aged 50 (±5) who take Diflucan
  • 7.15% for females aged 50 (±5) who take Topamax
Fever
  • 10.5% for females aged 50 (±5) who take Diflucan
Headache (pain in head)
  • 8.04% for females aged 50 (±5) who take Topamax
Hypoaesthesia (reduced sense of touch or sensation)
  • 5.35% for females aged 50 (±5) who take Diflucan
Hypotension (abnormally low blood pressure)
  • 5.42% for females aged 50 (±5) who take Diflucan
Nausea (feeling of having an urge to vomit)
  • 10.6% for females aged 50 (±5) who take Diflucan
  • 8.0% for females aged 50 (±5) who take Topamax
Nausea and vomiting
  • 5.82% for females aged 50 (±5) who take Diflucan
Oedema peripheral (superficial swelling)
  • 5.13% for females aged 50 (±5) who take Diflucan
Pain
  • 9.98% for females aged 50 (±5) who take Diflucan
  • 5.17% for females aged 50 (±5) who take Topamax
Pneumonia
  • 5.75% for females aged 50 (±5) who take Diflucan
Rashes (redness)
  • 5.32% for females aged 50 (±5) who take Diflucan
Stress and anxiety
  • 6.61% for females aged 50 (±5) who take Diflucan
Thrombocytopenia (decrease of platelets in blood)
  • 6.51% for females aged 50 (±5) who take Diflucan
Weakness
  • 7.68% for females aged 50 (±5) who take Diflucan

Most common co-existing conditions:

Depression
  • 13.52% for females aged 50 (±5) who take Topamax
High blood cholesterol
  • 5.42% for females aged 50 (±5) who take Topamax
High blood pressure
  • 5.78% for females aged 50 (±5) who take Topamax
Multiple myeloma (cancer of the plasma cells)
  • 6.11% for females aged 50 (±5) who take Diflucan
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 8.81% for females aged 50 (±5) who take Topamax
Pain
  • 8.91% for females aged 50 (±5) who take Topamax
  • 6.06% for females aged 50 (±5) who take Diflucan
Stress and anxiety
  • 6.63% for females aged 50 (±5) who take Topamax
back to top

Male

Males aged 50 to 59 :

4,729 related reports were analyzed:

Most common symptoms:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  • 6.24% for males aged 50 (±5) who take Diflucan
Anaemia (lack of blood)
  • 5.24% for males aged 50 (±5) who take Diflucan
Diarrhea
  • 6.67% for males aged 50 (±5) who take Diflucan
Drug ineffective
  • 6.86% for males aged 50 (±5) who take Topamax
Fatigue (feeling of tiredness)
  • 5.74% for males aged 50 (±5) who take Diflucan
  • 5.63% for males aged 50 (±5) who take Topamax
Fever
  • 12.09% for males aged 50 (±5) who take Diflucan
Headache (pain in head)
  • 6.17% for males aged 50 (±5) who take Topamax
Hypotension (abnormally low blood pressure)
  • 5.62% for males aged 50 (±5) who take Diflucan
Memory loss
  • 5.4% for males aged 50 (±5) who take Topamax
Nausea (feeling of having an urge to vomit)
  • 6.26% for males aged 50 (±5) who take Diflucan
Pneumonia
  • 7.43% for males aged 50 (±5) who take Diflucan
Rashes (redness)
  • 5.36% for males aged 50 (±5) who take Diflucan
Renal failure acute (rapid kidney dysfunction)
  • 5.71% for males aged 50 (±5) who take Diflucan
Thrombocytopenia (decrease of platelets in blood)
  • 10.31% for males aged 50 (±5) who take Diflucan
Weakness
  • 5.71% for males aged 50 (±5) who take Diflucan
Weight decreased
  • 5.01% for males aged 50 (±5) who take Topamax

Most common co-existing conditions:

Depression
  • 9.33% for males aged 50 (±5) who take Topamax
High blood cholesterol
  • 6.4% for males aged 50 (±5) who take Topamax
High blood pressure
  • 7.56% for males aged 50 (±5) who take Topamax
Hiv infection
  • 8.04% for males aged 50 (±5) who take Diflucan
Multiple myeloma (cancer of the plasma cells)
  • 8.36% for males aged 50 (±5) who take Diflucan
Pain
  • 7.94% for males aged 50 (±5) who take Topamax
  • 5.19% for males aged 50 (±5) who take Diflucan
back to top

Related studies

Diflucan

Diflucan has active ingredients of fluconazole. It is often used in vaginal yeast infection. (latest outcomes from Diflucan 21,704 users)

Topamax

Topamax has active ingredients of topiramate. It is often used in migraine. (latest outcomes from Topamax 38,820 users)

Diflucan and Topamax

Related publications that referenced our studies


Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

Can you answer these questions

More questions for: Diflucan, Topamax

You may be interested in these posts

More posts for: Diflucan, Topamax

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.